Northern Trust Portfolio holdings
AUM
$727B
1-Year Return
23.08%
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
This Quarter Return
+0.44%
1 Year Return
+23.08%
3 Year Return
+97.56%
5 Year Return
+177.34%
10 Year Return
+414.74%
AUM
$565B
AUM Growth
-$2.74B
(-0.48%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
4,828
New
242
Increased
1,430
Reduced
2,708
Closed
176
Top Buys
| 1 |
Moderna
MRNA
|
+$581M |
| 2 |
Johnson & Johnson
JNJ
|
+$569M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$437M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$394M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$630M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$359M |
| 4 |
JPMorgan Chase
JPM
|
+$332M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| 1 | Technology | 23.13% |
| 2 | Financials | 12.67% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Primis Financial Corp
FRST
$269M
| $3.01M | ﹤0.01% |
208,011
-8,438
| -4% | -$122K |
|
3052
Arbutus Biopharma
ABUS
$855M
| $3.01M | ﹤0.01% |
700,504
-18,655
| -3% | -$80K |
|
|
SMMF
3053
DELISTED
Summit Financial Group, Inc.
SMMF
| $3M | ﹤0.01% |
122,580
-3,313
| -3% | -$81.2K |
|
3054
KRONOS Worldwide
KRO
$694M
| $2.98M | ﹤0.01% |
239,945
-16,703
| -7% | -$207K |
|
3055
Vanguard Financials ETF
VFH
$12.9B
| $2.98M | ﹤0.01% |
32,144
+7,381
| +30% | +$684K |
|
|
AMPE
3056
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.98M | ﹤0.01% |
5,981
-187
| -3% | -$93.1K |
|
3057
ClearPoint Neuro
CLPT
$298M
| $2.98M | ﹤0.01% |
167,655
-8,771
| -5% | -$156K |
|
3058
BeyondSpring
BYSI
$73.4M
| $2.96M | ﹤0.01% |
188,077
-29,641
| -14% | -$467K |
|
3059
Confluent
CFLT
$6.63B
| $2.96M | ﹤0.01% |
+49,694
| New | +$2.96M |
|
3060
Applied Therapeutics
APLT
$60.6M
| $2.96M | ﹤0.01% |
178,200
-11,804
| -6% | -$196K |
|
3061
Peoples Financial Services
PFIS
$525M
| $2.95M | ﹤0.01% |
64,834
-1,573
| -2% | -$71.7K |
|
3062
Payoneer
PAYO
$2.34B
| $2.95M | ﹤0.01% |
+344,948
| New | +$2.95M |
|
3063
Krispy Kreme
DNUT
$541M
| $2.95M | ﹤0.01% |
+210,445
| New | +$2.95M |
|
3064
Aveanna Healthcare
AVAH
$1.76B
| $2.94M | ﹤0.01% |
366,826
-42,585
| -10% | -$342K |
|
|
NOAH
3065
Noah Holdings
NOAH
$781M
| $2.94M | ﹤0.01% |
79,108
-127,922
| -62% | -$4.75M |
|
3066
Ecopetrol
EC
$18.8B
| $2.93M | ﹤0.01% |
204,425
-261,275
| -56% | -$3.75M |
|
|
SWI
3067
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.93M | ﹤0.01% |
175,323
-118,774
| -40% | -$1.99M |
|
3068
Gerdau
GGB
$6.03B
| $2.93M | ﹤0.01% |
749,933
-61,899
| -8% | -$242K |
|
|
EBET
3069
DELISTED
EBET, INC. Common Stock
EBET
| $2.92M | ﹤0.01% |
2,901
+2,809
| +3,053% | +$2.83M |
|
3070
Donegal Group Class A
DGICA
$711M
| $2.92M | ﹤0.01% |
201,580
-8,087
| -4% | -$117K |
|
|
ESTE
3071
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $2.92M | ﹤0.01% |
317,394
-1,620
| -0.5% | -$14.9K |
|
|
FUV
3072
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $2.92M | ﹤0.01% |
12,769
-536
| -4% | -$123K |
|
3073
Vanguard ESG International Stock ETF
VSGX
$5.1B
| $2.91M | ﹤0.01% |
47,171
| – | – |
|
3074
Preformed Line Products
PLPC
$979M
| $2.91M | ﹤0.01% |
44,767
-1,362
| -3% | -$88.6K |
|
3075
Spyre Therapeutics
SYRE
$945M
| $2.91M | ﹤0.01% |
14,628
-106
| -0.7% | -$21.1K |
|